Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies.

MedScience·2026
Same author

A benzothiadiazole-based polar fluorescent probe for targeting lipid droplets in living cells.

Analytical methods : advancing methods and applications·2025
Same author

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Encapsulated in M2 Macrophage Cell Membrane Targeted to Inhibit Joint Periprosthetic Inflammation.

ACS applied materials & interfaces·2025
Same author

Fused extracellular vesicles from M<sub>2</sub> macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis.

Journal of extracellular vesicles·2024
Same author

<i>Cynanchum paniculatum</i> (Bunge) Kitag. ex H.Hara inhibits pancreatic cancer progression by inducing caspase-dependent apoptosis and suppressing TGF-β-mediated epithelial-mesenchymal transition.

Frontiers in pharmacology·2024
Same author

Enhanced Osteolysis Targeted Therapy through Fusion of Exosomes Derived from M2 Macrophages and Bone Marrow Mesenchymal Stem Cells: Modulating Macrophage Polarization.

Small (Weinheim an der Bergstrasse, Germany)·2023

Related Experiment Video

Updated: Sep 6, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528

SIX3 function in cancer: progression and comprehensive analysis.

Tian-Liang Ma1,2, Peng Zhu3, Jing-Xian Chen3

  • 1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Cancer Gene Therapy
|June 28, 2022
PubMed
Summary

Sine oculis homeobox 3 (SIX3) acts as both a cancer suppressor and promoter, depending on the specific cancer. Understanding SIX3

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K

Related Experiment Videos

Last Updated: Sep 6, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The homeobox gene family, including Sine oculis homeobox (SIX) genes, plays critical roles in cellular functions.
  • SIX3, a core member of the SIX gene family, exhibits dual roles in cancer, acting as either a tumor suppressor or promoter.
  • SIX3's function is intricately linked to its modulation of cancer-promoting and cancer-inhibiting signaling pathways.

Purpose of the Study:

  • To review and analyze the current research progress on the role of SIX3 in various human tumors.
  • To elucidate the reasons behind SIX3's differential roles in different cancer types.
  • To explore potential new therapeutic strategies targeting SIX3 for cancer treatment.

Main Methods:

  • Comprehensive literature review of studies investigating SIX3 expression and function in cancer.
  • Analysis of SIX3's involvement in key cellular processes such as cell cycle, proliferation, migration, and angiogenesis.
  • Examination of SIX3's interaction with signaling pathways, particularly the Wnt pathway.

Main Results:

  • Low SIX3 expression is observed in most malignant tumors, correlating with enhanced cell cycle, proliferation, migration, and angiogenesis.
  • Restoration of SIX3 expression can suppress cancer, often through direct or indirect inhibition of the Wnt pathway.
  • Conversely, SIX3 acts as a tumor promoter in specific cancers like esophageal and gastric cancer, where its repression improves prognosis.

Conclusions:

  • SIX3 exhibits context-dependent roles in tumorigenesis, functioning as a tumor suppressor in some cancers and a promoter in others.
  • The differential roles of SIX3 are influenced by its impact on distinct cancer-related signaling pathways.
  • Targeting SIX3 offers potential for novel, cancer-specific therapeutic strategies.